Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 5Completed 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 8Stomach Neoplasms 3Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Advanced Gastric Cancer 2Thymic epithelial tumor 1Solid Tumor 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Cancer Recurrent 1Neuroendocrine Tumors 1Locally Advanced Gastric Cancer 1Liver Neoplasms 1Liposarcoma 1HR+/HER2-breast Cancer 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

tislelizumab 7Paclitaxel 5Radiotherapy 4Oxaliplatin 3Immune Checkpoint Inhibitors 3Carboplatin 3nedaplatin 2Radiation 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cisplatin 2Albumin-Bound Paclitaxel 2tranilast 1toripalimab 1sintilimab 1irinotecan sucrosofate 1camrelizumab 1apatinib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Robotic Surgical Procedures 1Radiosurgery 1Pemetrexed 1Patient Reported Outcome Measures 1Observation 1Nutrition Therapy 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Neoplasms × apatinib × Clear all
NCT06464614 2024-06-18

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

The First Affiliated Hospital of Henan University of Science and Technology

Phase 2 Not yet recruiting
54 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡